Seven and Eight Biopharmaceuticals Inc.

Eikon Therapeutics has raised another venture capital mega-round – bringing its total funding to date to $1.1bn – to build what it calls a “21st century biotechnology company.” The new financing will

Eikon Therapeutics, Inc. announced the first venture capital mega-round of $100m or more for June, revealing that it raised $106m in the first tranche of a series C funding round on 1 June. The finan

Cancer vaccines have gained in prominence over the last couple of decades, as the emergence of immuno-oncology has validated the immune system’s essential role in maintaining healthy cell division. Th

Biopharmaceutical start-up financings declined 17% from $3.44bn in the first quarter to $2.84bn in the second quarter, according to Strategic Transactions . However, young drug developers continue to